ARRAY BIOPHARMA INC Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARRAY BIOPHARMA INC for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 2.46 | 20,000 | 49,200 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 3.51 | 20,000 | 70,200 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 1.74 | 15,000 | 26,100 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Option Exercise | M | 3.37 | 15,000 | 50,550 | 0 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Sell | S | 8.00 | 70,000 | 560,070 | 3,585 | 73.6 K to 3.6 K (-95.13 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 2.46 | 20,000 | 49,200 | 73,585 | 53.6 K to 73.6 K (+37.32 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 3.51 | 20,000 | 70,200 | 53,585 | 33.6 K to 53.6 K (+59.55 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 1.74 | 15,000 | 26,100 | 33,585 | 18.6 K to 33.6 K (+80.71 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | LEFKOFF KYLE | Director | Buy | M | 3.37 | 15,000 | 50,550 | 18,585 | 3.6 K to 18.6 K (+418.41 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrews R | SVP, Commercial Ope ... | Option Exercise | M | 0.00 | 32,069 | 0 | 32,069 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrews R | SVP, Commercial Ope ... | Sell | S | 8.25 | 21,576 | 178,002 | 0 | 21.6 K to 0 (-100.00 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrews R | SVP, Commercial Ope ... | Payment of Exercise | F | 7.96 | 10,493 | 83,524 | 21,576 | 32.1 K to 21.6 K (-32.72 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrews R | SVP, Commercial Ope ... | Buy | M | 7.96 | 32,069 | 255,269 | 32,069 | 0 to 32.1 K |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 17,440 | 0 | 17,440 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Payment of Exercise | F | 7.96 | 5,805 | 46,208 | 11,635 | 17.4 K to 11.6 K (-33.29 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 7.96 | 17,440 | 138,822 | 17,440 | 0 to 17.4 K |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | M | 0.00 | 22,906 | 0 | 22,906 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Payment of Exercise | F | 7.96 | 7,542 | 60,034 | 15,364 | 22.9 K to 15.4 K (-32.93 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Buy | M | 7.96 | 22,906 | 182,332 | 22,906 | 0 to 22.9 K |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 77,881 | 0 | 77,881 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 8.25 | 40,000 | 330,000 | 12,927 | 52.9 K to 12.9 K (-75.58 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Payment of Exercise | F | 7.96 | 24,954 | 198,634 | 52,927 | 77.9 K to 52.9 K (-32.04 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 7.96 | 77,881 | 619,933 | 77,881 | 0 to 77.9 K |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 11,453 | 0 | 11,453 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 7.96 | 4,033 | 32,103 | 7,420 | 11.5 K to 7.4 K (-35.21 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 7.96 | 11,453 | 91,166 | 11,453 | 0 to 11.5 K |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | SNITMAN DAVID | COO and VP, Busines ... | Option Exercise | M | 0.00 | 11,453 | 0 | 11,453 | |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | SNITMAN DAVID | COO and VP, Busines ... | Payment of Exercise | F | 7.96 | 3,976 | 31,649 | 7,477 | 11.5 K to 7.5 K (-34.72 %) |
| Mar 04 2015 | ARRY | ARRAY BIOPHARMA IN ... | SNITMAN DAVID | COO and VP, Busines ... | Buy | M | 7.96 | 11,453 | 91,166 | 11,453 | 0 to 11.5 K |